SMSomashekhar M. Metri

Somashekhar M. Metri

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Somashekhar M. Metri has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Phytochemical Horizons in Anticancer Drug Discovery: From Lead Molecules to Clinical Prospects

    by Mahesh Agasa Ramu, Suvarna Lakshmi Gunturu, Somashekhar Metri, Vimal Kumar S, Chanda Ranjan

    In the present day, there is a great concern about the second deadliest disease, cancer. An enormous number of mortalities rate is increasing every year because of cancer despite a few inter-cessions accessible. Advancements in potency with fewer side effects make anticancer treatment a promising area of drug development. Phytochemicals can be potent in this manner. These bioactive natural products are unique and target malignant cells differentially, with little alteration in normal cells. Phytochemicals exhibit pleiotropic activity and, more specifically, are among the most promis-ing candidates for advanced cancer therapy. This chapter summarises the various lead anticancer phytochemicals and the complex drug development processes associated with natural products. We discuss the specific challenges encountered during the discovery and development of anti-malignant phytochemicals, as well as the current clinical landscape. By examining successful transitions of dif-ferent phytochemicals from lead molecules to clinical candidates, this review highlights the scope and potential of plant-derived compounds in revolutionising the treatment of cancer. This review highlights the scope and potential of plant-derived compounds to revolutionise cancer treatment.

  • Nanotechnology in gamete health: Improving egg and sperm viability

    by Sajid Ali, Somashekhar M. Metri, Vettrivel Arul, K.P. Jaiganesh, Shyam Wamanrao Rangari, Neha Singh, K. Thejomoorthy

  • Nanotechnology in follicle tracking and ovarian stimulation

    by Gaurav Tiwari, Ranjit Vinayak Gadhave, Somashekhar M Metri, Dhruv Dev, Shubhangi Vijaykumar Pawar, Senthil Prabhu Rajendran, Punam Radhesham Kela

  • Open Access

    Phytochemical Profile and α‐Amylase Inhibitory Activity of Pomegranate Peel Extract: An In Silico and In Vitro Investigation

    by Shankar Thapa, Deepti Pandey, Mahalakshmi Suresha Biradar, Monica Arora, Shithin Ann Varghese, Akila Elias, Aleesha Mujeeb Shaheen, Somashekhar M. Metri, Shaik Sadik, Sreeharsha Nagaraja, et al.

    Diabetes is among the top ten causes of mortality and morbidity. Diabetes has been increasing faster in low‐ and middle‐income nations than it has been rising in high‐income countries. This study explores the phytochemical profiling and in vitro α‐amylase inhibitory activity of the methanolic extract of Nepalese‐origin pomegranate peels. Phytochemical analysis using FT‐IR and LC–MS identified key bioactive compounds, including ellagic acid, punicalagin, punicalin, gallic acid, and ellagic acid‐O‐xylopyranoside, contributing to the observed enzymatic inhibition. Molecular docking studies revealed strong binding affinities of punicalagin (−11.6 kcal/mol) and ellagic acid‐O‐xylopyranoside (−10.6 kcal/mol) to α‐amylase, suggesting potential antidiabetic properties. MD simulations confirmed the stability of these interactions over a 100 ns timeframe, reinforcing their role in enzyme inhibition. The in vitro α‐amylase inhibition assay demonstrated comparable activity of pomegranate peel extract (IC 50 = 137.74 μg/mL) to reference drug acarbose (IC 50 = 222.19 μg/mL). These findings provide molecular insights into the bioactivity of pomegranate peel extracts, highlighting their potential in diabetes management.